论文部分内容阅读
目的:探讨小儿肠炎药敏试验情况以及临床治疗情况分析。方法:选择我院治疗的小儿肠炎患儿84例作为研究对象,采取随机数字表法分为观察组和对照组,每组各42例,对照组给予阿莫西林治疗,观察组对患儿进行便培养观察敏感病原菌情况,同时给予患儿头孢哌酮舒巴坦进行治疗,记录两组临床疗效。结果:小儿肠炎便培养以福氏志贺菌为主,进行敏感菌检测试验排在前三位的为头孢哌酮舒巴坦、阿米卡星和环丙沙星。观察组临床治疗总有效率高于对照组,经统计学分析差异有统计学意义(P<0.05)。结论:小儿肠炎培养感染菌主要为福氏痢疾杆菌,建议采用舒普深和β-内酰胺酶抑菌药物作为重症患儿的首选抗菌素,但是临床应根据患儿药敏试验结果和身体情况及时调整合理选择抗生素。
Objective: To investigate the drug susceptibility test of children with enteritis and clinical analysis of the situation. Methods: 84 cases of infantile enteritis treated in our hospital were selected as the research object. The random number table was divided into observation group and control group, 42 cases in each group. The control group was treated with amoxicillin. The observation group was performed on children They were cultured to observe the situation of sensitive pathogens, while patients given cefoperazone sulbactam for treatment, the clinical efficacy of both groups were recorded. Results: Pediatric enteritis was mainly cultured with Shigella flexneri and cefoperazone sulbactam, amikacin and ciprofloxacin were the first three to be tested. The total effective rate of observation group was higher than that of control group, and the difference was statistically significant (P <0.05). Conclusions: The main pathogens of infection in children with enteritis are Shigella flexneri. Schisandra and β-lactamase antibacterials are recommended as the first choice antibiotics in children with severe enteritis. However, according to the result of drug susceptibility test and physical condition in children, Adjust the rational choice of antibiotics.